These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32339851)

  • 21. Efficacy and validity of guideline-concordant treatment according to the JRS guidelines for the managements of pneumonia in adults updated in 2017 for nursing and healthcare-associated pneumonia. A propensity-matching score analysis.
    Asai N; Ohashi W; Watanabe H; Shiota A; Shibata Y; Kato H; Sakanashi D; Hagihara M; Koizumi Y; Yamagishi Y; Suematsu H; Mikamo H
    J Infect Chemother; 2022 Jan; 28(1):24-28. PubMed ID: 34580007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia.
    Webb BJ; Dangerfield BS; Pasha JS; Agrwal N; Vikram HR
    Respir Med; 2012 Nov; 106(11):1606-12. PubMed ID: 22917808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia].
    Yamasaki K; Yatera K; Kawanami T; Sasahara Y; Hata R; Uchimura K; Tachiwada T; Naito K; Kato K; Takaki T; Shimabukuro I; Shiraishi T; Oda K; Hara K; Chojin Y; Suzuki Y; Akata K; Ogoshi T; Tokuyama S; Inoue N; Noguchi S; Nishida C; Orihashi T; Yoshida Y; Kawanami Y; Taura Y; Ishimoto H; Obata H; Awaya Y; Tsuda T; Yoshii C; Mukae H
    Jpn J Antibiot; 2014 Feb; 67(1):23-32. PubMed ID: 24809206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiological analysis and epidemiological comparison among adult CAP and NHCAP patients in Okinawa, Japan.
    Parrott G; Nebeya D; Kinjo T; Miyagi K; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2017 Jul; 23(7):452-458. PubMed ID: 28431934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection failure rate of chest radiography for the identification of nursing and healthcare-associated pneumonia.
    Miyashita N; Kawai Y; Tanaka T; Akaike H; Teranishi H; Wakabayashi T; Nakano T; Ouchi K; Okimoto N
    J Infect Chemother; 2015 Jul; 21(7):492-6. PubMed ID: 25842163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory biomarkers are not useful for predicting prognosis in nursing and healthcare-associated pneumonia: A prospective, cohort study.
    Ito A; Ishida T; Nakanishi Y; Yamazaki A; Washio Y
    J Infect Chemother; 2022 May; 28(5):623-630. PubMed ID: 35153137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nosocomial pneumonia: Current etiology and impact on antimicrobial therapy.
    Gamazo JJ; Candel FJ; González Del Castillo J
    Rev Esp Quimioter; 2023 Nov; 36 Suppl 1(Suppl 1):9-14. PubMed ID: 37997863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of efficacy and safety of lascufloxacin for nursing and healthcare associated pneumonia: single-arm, open-label clinical trial: A study protocol.
    Hosogaya N; Takazono T; Ota K; Kiya R; Shirai Y; Kawasaki R; Yano H; Morimoto S; Nakao R; Kanamaru Y; Yoshino Y; Ishikawa Y; Fukushima C; Yamamoto H; Izumikawa K; Yanagihara K; Mukae H
    Medicine (Baltimore); 2023 Feb; 102(8):e33092. PubMed ID: 36827005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia.
    Rothberg MB; Zilberberg MD; Pekow PS; Priya A; Haessler S; Belforti R; Skiest D; Lagu T; Higgins TL; Lindenauer PK
    J Antimicrob Chemother; 2015 May; 70(5):1573-9. PubMed ID: 25558075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment Trends and Outcomes in Healthcare-Associated Pneumonia.
    Haessler S; Lagu T; Lindenauer PK; Skiest DJ; Priya A; Pekow PS; Zilberberg MD; Higgins TL; Rothberg MB
    J Hosp Med; 2017 Nov; 12(11):886-891. PubMed ID: 29091975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department.
    Angrill N; Gallego M; Font J; Vallés J; Morón A; Monsó E; Rello J
    BMC Pulm Med; 2020 Apr; 20(1):83. PubMed ID: 32245452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in physical function after hospitalization in patients with nursing and healthcare-associated pneumonia.
    Kato T; Miyashita N; Kawai Y; Horita N; Yano S; Oka Y; Oda T; Okimoto N
    J Infect Chemother; 2016 Oct; 22(10):662-6. PubMed ID: 27493023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia.
    Kamata K; Suzuki H; Kanemoto K; Tokuda Y; Shiotani S; Hirose Y; Suzuki M; Ishikawa H
    J Infect Chemother; 2015 Aug; 21(8):596-603. PubMed ID: 26070781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effect of biapenem on nursing and healthcare-associated pneumonia (NHCAP).
    Okimoto N; Kawai Y; Katoh T; Hayashi T; Kurihara T; Miyashita N
    J Infect Chemother; 2015 Aug; 21(8):592-5. PubMed ID: 26050019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.
    Schweitzer VA; van Werkhoven CH; van Heijl I; Smits RF; Boel CHE; Bonten MJM; Postma DF; Oosterheert JJ
    Neth J Med; 2018 Nov; 76(9):389-396. PubMed ID: 30465653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for acquiring potentially drug-resistant pathogens in immunocompetent patients with pneumonia developed out of hospital.
    Jeong BH; Koh WJ; Yoo H; Park HY; Suh GY; Chung MP; Kwon OJ; Jeon K
    Respiration; 2014; 88(3):190-8. PubMed ID: 24994099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.